Skip to main content

Table 2 Maternal adverse outcomes of pre-HDP patients and healthy pregnancies

From: Serum complement proteomics reveal biomarkers for hypertension disorder of pregnancy and the potential role of Clusterin

Factors

The screening and validation set

Control (n = 148)

Pre-HDP (n = 148)

P

N (%)

N (%)

Maternal adverse outcomes

 Parturient at admission, n (%)

126 (86.7)

102 (73.2)

0.001

 PROM, n (%)

32 (24.06)

27 (19.57)

0.97

 Umbilical cord around neck, n (%)

26 (19.12)

21 (15.79)

0.47

 Caesarean section, n (%)

6 (4.42)

61 (45.86)

< 0.001

 Postpartum haemorrhage, n (%)

2 (1.47)

0 (0)

0.16

 Oedema of lower limbs, n (%)

3 (2.17)

18 (13.53)

0.08

 Soreness of waist, n (%)

0 (0)

7 (5.26)

/

 Cramps, n (%)

0 (0)

0 (0)

/

Infant

 Birth weight (g)

3196.15 ± 320.21

2823.69 ± 680.40

< 0.001

Paternal condition

 Paternal age (years)

31.72 ± 6.06

31.52 ± 5.83

0.81

  1. PROM Premature rupture of membranes. Data are presented as the mean ± SD (standard deviation) and analysed by Student’s t-test. Data are presented as n (%) and were analysed using a chi-square test or Fisher’s exact test